|
News for Pain Therapeutics
|
| Date |
Headline |
|
Apr 12, 2018 11:15 AM
|
Pain Therapeutics (PTIE) Shares March Higher, Can It Continue?
|
|
Apr 04, 2018 08:30 AM
|
Research Report Identifies Pain Therapeutics, Kearny Financial, Titan Machinery, Financial Institutions, NV5 Global, and Haynes International with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
|
|
Mar 20, 2018 08:00 AM
|
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER
|
|
Mar 19, 2018 11:36 AM
|
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pain Therapeutics, Inc.
|
|
Mar 19, 2018 07:33 AM
|
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Pain Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
|
|
Mar 19, 2018 07:00 AM
|
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER®
|
|
Mar 06, 2018 01:36 PM
|
Analyst: Durect's Phase 2 Trials Are An Entry Point For Investors
|
|
Mar 01, 2018 01:55 PM
|
How Should You Think About Pain Therapeutics Inc’s (NASDAQ:PTIE) Risks?
|
|
Mar 01, 2018 08:00 AM
|
FDA Accepts REMOXY® NDA for Review, Sets PDUFA Date of August 7, 2018
|
|
Feb 14, 2018 08:00 AM
|
DURECT Announces Resubmission of REMOXY® ER New Drug Application by its licensee, Pain Therapeutics
|
